Watch industry experts from around the world discuss the findings from the 2021 “Beyond Intervention” research covering challenges in the earliest stages of the vascular patient care, including health equity barriers. Nick West, M.D. Chief Medical Officer and DVP Global Medical Affairs, Abbott’s Vascular Business, is joined by Abbott colleague Jennifer Jones-McMeans, PhD, DVP of Clinical Affairs, David G. Armstrong, D.P.M., M.D., PhD, Progressor of Surgery, Director, USC, and David Rhew, M.D. Chief Medical Officer and VP of Healthcare at Microsoft.
Patient Experience: Why Health Equity Matters and How Technology Is Shaping the Future
MAT-2301412 v1.0
Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company.
Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company.
The following content is intended for Healthcare Professionals except for those in France. Some of the content is not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011, article 34.
Si vous êtes un professionnel de santé exerçant en France ou dans les territoires Français, veuillez visiter notre site en français.
Do you want to continue?